RxDoctor Payments Data

Lisa Walker

Nurse Practitioner · Virginia Beach, VANPI 1912340902

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 573 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,787in general payments, 2019–2025

Across 573 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lundbeck LLC$2K
  • Collegium Pharmaceutical, Inc.$948
  • Pfizer$765
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$454
  • Amgen$394
  • plus $4K from 36 others

What the payments were for

  • Food & beverage$10,775100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,787 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl68$112,378
Nurtec OdtRimegepant Sulfate29$55,177
Oxymorphone Hcl ErOxymorphone Hcl23$31,241
Fentanyl94$22,351
Oxycodone Hcl531$19,571
Nucynta ErTapentadol Hcl11$19,121
UbrelvyUbrogepant12$14,625
Xtampza ErOxycodone Myristate16$14,298
Aimovig AutoinjectorErenumab-Aooe12$8,542
SymproicNaldemedine Tosylate19$8,503
Morphine Sulfate ErMorphine Sulfate157$7,358
Hydromorphone Hcl148$5,932
MovantikNaloxegol Oxalate13$5,333
Lidocaine22$4,163
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen73$3,222

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$765$55,17729 claims
Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er$948$33,41927 claims
AbbVieUbrelvy$2,526$14,62512 claims
Redhill Biopharma Inc.Movantik$76$5,33313 claims
Hikma Pharmaceuticals USAMorphine Sulfate$26$2,56046 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →